[go: up one dir, main page]

AR009379A1 - Derivados de acido piperidin-cetocarboxilico, su uso y composiciones farmaceuticas que los contienen - Google Patents

Derivados de acido piperidin-cetocarboxilico, su uso y composiciones farmaceuticas que los contienen

Info

Publication number
AR009379A1
AR009379A1 ARP970104718A ARP970104718A AR009379A1 AR 009379 A1 AR009379 A1 AR 009379A1 AR P970104718 A ARP970104718 A AR P970104718A AR P970104718 A ARP970104718 A AR P970104718A AR 009379 A1 AR009379 A1 AR 009379A1
Authority
AR
Argentina
Prior art keywords
derivatives
cetocarboxilico
piperidin
contain
acid
Prior art date
Application number
ARP970104718A
Other languages
English (en)
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of AR009379A1 publication Critical patent/AR009379A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de ácido piperidin-cetocarboxílico de la formula (I), y sus formas tautomeras e isomeras, así como las sales fisiologicamente compatiblesde los mismos, en donde preferentemente, los sustituyentes son: R1 es -C(=O)R4, -SO2-R4-; R2 es -C1-C6-alquilo, ramificado y sin ramificar,-CH2- Ph y CH2-piridilo; R3 es -OR6 y -NHR6 y las sales fisiologicamente toleradas que se obtienen por reaccion de los compuestos (I) con una sal ouna base apropiada. Estos compuestos son utiles para preparar medicamentos y actuan como inhibidores de cisteína-proteasas, controlando de estamanera enfermedades que van acompanadas de una elevada actividad de este tipo de enzimas.
ARP970104718A 1996-10-15 1997-10-14 Derivados de acido piperidin-cetocarboxilico, su uso y composiciones farmaceuticas que los contienen AR009379A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19642591A DE19642591A1 (de) 1996-10-15 1996-10-15 Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung

Publications (1)

Publication Number Publication Date
AR009379A1 true AR009379A1 (es) 2000-04-12

Family

ID=7808858

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104718A AR009379A1 (es) 1996-10-15 1997-10-14 Derivados de acido piperidin-cetocarboxilico, su uso y composiciones farmaceuticas que los contienen

Country Status (24)

Country Link
US (1) US6380220B1 (es)
EP (1) EP0934273A1 (es)
JP (1) JP2001501955A (es)
KR (1) KR20000049130A (es)
CN (1) CN1239950A (es)
AR (1) AR009379A1 (es)
AU (1) AU736754B2 (es)
BG (1) BG103338A (es)
BR (1) BR9711908A (es)
CA (1) CA2268917A1 (es)
CO (1) CO4930264A1 (es)
CZ (1) CZ126899A3 (es)
DE (1) DE19642591A1 (es)
HR (1) HRP970549A2 (es)
HU (1) HUP9904104A3 (es)
IL (1) IL129089A0 (es)
NO (1) NO991761L (es)
NZ (1) NZ334979A (es)
PL (1) PL332720A1 (es)
RU (1) RU2189974C2 (es)
SK (1) SK38599A3 (es)
TR (1) TR199900819T2 (es)
WO (1) WO1998016512A1 (es)
ZA (1) ZA979175B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19817459A1 (de) 1998-04-20 1999-10-21 Basf Ag Neue heterozyklische substituierte Amide, Herstellung und Anwendung
BR9909774A (pt) 1998-04-20 2000-12-19 Basf Ag Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
EP1082308B1 (de) 1998-04-20 2009-04-01 Abbott GmbH & Co. KG Heterocyclisch substituierte amide als calpainhemmer
HRP20000788A2 (en) * 1998-04-20 2001-06-30 Basf Ag Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
WO2001014331A2 (en) * 1999-08-24 2001-03-01 Regents Of The University Of California Non-quinoline inhibitors of malaria parasites
NZ511997A (en) 1999-09-29 2004-12-24 Ortho Mcneil Pharm Inc Isonipecotamides for the treatment of integrin-mediated disorders
WO2002002546A1 (en) 2000-06-30 2002-01-10 Seikagaku Corporation EPOXYCARBOXYLIC ACID AMIDES, AZIDES AND AMINO ALCOHOLS AND PROCESSES FOR PREPARATION OF α-KETO AMIDES BY USING THEM
DE10114762A1 (de) * 2001-03-26 2002-10-02 Knoll Gmbh Verwendung von Cysteinprotease-Inhibitoren
JP2004529918A (ja) 2001-04-09 2004-09-30 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド インテグリンに由来する疾患の治療のためのキナゾリンおよびキナゾリン類似化合物
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
WO2005016883A2 (en) * 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
JP4769192B2 (ja) * 2003-10-24 2011-09-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド カテプシン阻害剤としての新規な化合物及び組成物
CN101616908B (zh) 2006-12-29 2014-09-10 Abbvie德国有限责任两合公司 羧酰胺化合物及它们作为钙蛋白酶抑制剂的用途
TWI453019B (zh) * 2007-12-28 2014-09-21 Abbvie Deutschland 甲醯胺化合物
TWI519530B (zh) 2009-02-20 2016-02-01 艾伯維德國有限及兩合公司 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
US8236798B2 (en) 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US8598211B2 (en) 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
US9051304B2 (en) 2009-12-22 2015-06-09 AbbVie Deutschland GmbH & Co. KG Carboxamide compounds and their use as calpain inhibitors V
WO2012076639A1 (en) 2010-12-09 2012-06-14 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors v
RU2014144285A (ru) 2012-04-03 2016-05-27 Эббви Дойчланд Гмбх Унд Ко. Кг Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина v
US10590084B2 (en) 2016-03-09 2020-03-17 Blade Therapeutics, Inc. Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
WO2018009417A1 (en) 2016-07-05 2018-01-11 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
CA3038331A1 (en) 2016-09-28 2018-04-05 Blade Therapeutics, Inc. Calpain modulators and therapeutic uses thereof
WO2018221546A1 (en) 2017-06-01 2018-12-06 Eisai R&D Management Co., Ltd. Pharmaceutical composition comprising pde9 inhibitor
US11311530B2 (en) 2017-06-01 2022-04-26 Eisai R&D Management Co., Ltd. Lewy body disease therapeutic agent containing pyrazoloquinoline derivative
RU2020130022A (ru) * 2018-03-28 2022-05-04 Блэйд Терапьютикс, Инк. Модуляторы кальпаина и их терапевтическое применение

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904298D0 (sv) * 1989-12-21 1989-12-21 Astra Ab New compounds
CA2098702A1 (en) * 1990-12-28 1992-06-29 James C. Powers Peptide ketoamides, ketoacids, and ketoesters
CA2098609A1 (en) 1990-12-28 1992-06-29 Raymond T. Bartus Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
CA2071621C (en) 1991-06-19 1996-08-06 Ahihiko Hosoda Aldehyde derivatives
EP0650368A1 (en) 1992-06-24 1995-05-03 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
US5541290A (en) 1993-06-24 1996-07-30 Harbeson; Scott L. Optically pure calpain inhibitor compounds

Also Published As

Publication number Publication date
CN1239950A (zh) 1999-12-29
IL129089A0 (en) 2000-02-17
US6380220B1 (en) 2002-04-30
DE19642591A1 (de) 1998-04-16
TR199900819T2 (xx) 1999-06-21
PL332720A1 (en) 1999-10-11
CZ126899A3 (cs) 1999-07-14
BG103338A (bg) 2000-01-31
WO1998016512A1 (de) 1998-04-23
HUP9904104A2 (hu) 2000-05-28
CO4930264A1 (es) 2000-06-27
BR9711908A (pt) 1999-08-24
HUP9904104A3 (en) 2001-01-29
SK38599A3 (en) 2000-04-10
KR20000049130A (ko) 2000-07-25
EP0934273A1 (de) 1999-08-11
NZ334979A (en) 2001-02-23
NO991761D0 (no) 1999-04-14
NO991761L (no) 1999-04-14
JP2001501955A (ja) 2001-02-13
ZA979175B (en) 1999-04-14
CA2268917A1 (en) 1998-04-23
HRP970549A2 (en) 1998-08-31
RU2189974C2 (ru) 2002-09-27
AU736754B2 (en) 2001-08-02
AU4777097A (en) 1998-05-11

Similar Documents

Publication Publication Date Title
AR009379A1 (es) Derivados de acido piperidin-cetocarboxilico, su uso y composiciones farmaceuticas que los contienen
UY27370A1 (es) Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células y métodos para su utilización
AR034475A1 (es) Derivados de androstano antiinflamatorios
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
AR245447A1 (es) Procedimiento para preparar derivados de 2,4-diamino-5-(biciclo-sustituido)metilpirimidinas.
PA8582801A1 (es) Nuevos derivados espirotricíclicos y su uso como inhibidores de la fosfodiesterasa
ES2087107T3 (es) Sulfonilaminocarboniltriazolinonas.
SE9203825D0 (sv) Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them
ES2175244T3 (es) Empleo de acido poliasparaginico y de sus sales.
UY29337A1 (es) N-aminometilensulfonamidas sustituidas, su preparación y su uso como medicamentos.
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
ES2149777T3 (es) Derivados de triazol que tienen actividad antifungica.
ES8703437A1 (es) Procedimiento para la preparacion de 4h-3,1-benzoxazin-4-- onas y compuestos relacionados
ES8507498A1 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
GT200200259A (es) Fungicidas
AR021068A1 (es) Benzoilpiridazinas y procedimientos para elaborarlas; preparados farmaceuticos que las contienen y procedimiento para elaborarlos, y utilizacion de dichasbenzoilpiridazinas
ES2083625T3 (es) Derivados de n-feniltiourea y uso farmaceutico de los mismos.
ES8700670A1 (es) Derivados de cefalosporina
ES2061710T3 (es) Nuevos derivados de l-prolina, su preparacion y sus aplicaciones biologicas.
AR024222A1 (es) Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
FI950842A0 (fi) Enkefalinaasin inhibiittoreina käyttökelpoisia uusia 2-substituoituja trisyklisiä indaani-2-merkaptoasetyyliamidijohdannaisia
AR050963A1 (es) Derivados bis-azaindolicos, su utilizacion farmaceutica como inhibidores de cinasas y su uso en la fabricacion de medicamentos para el tratamiento de los canceres.
ES2043070T3 (es) Procedimiento para la preparacion de derivados de la benzotiazolamina-2.
DK266686A (da) 1-aryl-5-alkoximinoalkylaminopyrazoler, fremgangsmaader til fremstilling deraf og deres anvendelse som herbicider og vaekstregulatorer
SV2004001457A (es) "sales estables del acido o-acetilsaliciclico con aminoacidos basicos ii" lea 35839-sv

Legal Events

Date Code Title Description
FA Abandonment or withdrawal